SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-18-035801
Filing Date
2018-08-07
Accepted
2018-08-07 16:36:37
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 AKCEA THERAPEUTICS, INC. 10-Q 6-30-2018 form10q.htm 10-Q 1100434
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 669944
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 7895
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 20286
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 12474
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 12312
7 EXHIBIT 32.1 ex32_1.htm EX-32.1 6588
14 image00001.jpg GRAPHIC 4675
15 image00002.jpg GRAPHIC 17624
  Complete submission text file 0001140361-18-035801.txt   6160386

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT akca-20180630.xml EX-101.INS 1039047
9 XBRL TAXONOMY EXTENSION SCHEMA akca-20180630.xsd EX-101.SCH 52964
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akca-20180630_cal.xml EX-101.CAL 53269
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akca-20180630_def.xml EX-101.DEF 247172
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20180630_lab.xml EX-101.LAB 674696
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20180630_pre.xml EX-101.PRE 348947
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38137 | Film No.: 18998621
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1